Marburgvirus Hijacks Nrf2-Dependent Pathway by Targeting Nrf2-Negative Regulator Keap1

Cell Reports

Volumn 6, Issue 6, 2014, Pages 1026-1036

  Page, Audrey ^a   Volchkova, Valentina A ^a   Reid, Saint Patrick ^a,b   Mateo, Mathieu ^a   Bagnaud Baule, Audrey ^a   Nemirov, Kirill ^a   Shurtleff, Amy C ^b   Lawrence, Philip ^a   Reynard, Oliver ^a   Ottmann, Michele ^a   Lotteau, Vincent ^a   Biswal, Shyam S ^c   Thimmulappa, Rajesh K ^c   Bavari, Sina ^b   Volchkov, Viktor E ^a  

^a CENTRE INTERNATIONAL DE RECHERCHE EN INFECTIOLOGIE   (France)

^b UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^c The Johns Hopkins University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KELCH LIKE ECH ASSOCIATED PROTEIN 1; PROTEIN VP24; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; VIRUS PROTEIN; COMPLEMENTARY DNA; HEME OXYGENASE 1; KARYOPHERIN; KARYOPHERIN ALPHA; KARYOPHERIN BETA; PROTEIN VP40; TRANSCRIPTION FACTOR GAL4; CYTOSKELETON PROTEIN; KEAP1 PROTEIN, HUMAN; KEAP1 PROTEIN, MOUSE; PROTEIN BINDING; SIGNAL PEPTIDE; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; INFLAMMATION; MARBURG VIRUS; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN TARGETING; VIRUS ATTACHMENT; AMINO ACID SUBSTITUTION; BINDING SITE; CELL SURVIVAL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; IMMUNOFLUORESCENCE TEST; IMMUNOPRECIPITATION; MARBURG HEMORRHAGIC FEVER; PLASMID; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; UBIQUITINATION; ANIMAL; C57BL MOUSE; GENETIC TRANSFECTION; HEK293 CELL LINE; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALIA; LAKE VICTORIA MARBURGVIRUS; MARBURGVIRUS; MUS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CYTOSKELETAL PROTEINS; HEK293 CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MARBURGVIRUS; MICE; MICE, INBRED C57BL; NF-E2-RELATED FACTOR 2; PROTEIN BINDING; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 84897095146     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.02.027     Document Type: Article

References (53)

1. Baize S., Leroy E.M., Georges A.J., Georges-Courbot M.C., Capron M., Bedjabaga I., Lansoud-Soukate J., Mavoungou E. Inflammatory responses in Ebola virus-infected patients. Clin. Exp. Immunol. 2002, 128:163-168.
2. Bamberg S., Kolesnikova L., Möller P., Klenk H.D., Becker S. VP24 of Marburg virus influences formation of infectious particles. J.Virol. 2005, 79:13421-13433.
3. Burdette D., Olivarez M., Waris G. Activation of transcription factor Nrf2 by hepatitis C virus induces the cell-survival pathway. J.Gen. Virol. 2010, 91:681-690.
4. Carvajal-Yepes M., Himmelsbach K., Schaedler S., Ploen D., Krause J., Ludwig L., Weiss T., Klingel K., Hildt E. Hepatitis C virus impairs the induction of cytoprotective Nrf2 target genes by delocalization of small Maf proteins. J.Biol. Chem. 2011, 286:8941-8951.
5. Cho H.Y., Imani F., Miller-DeGraff L., Walters D., Melendi G.A., Yamamoto M., Polack F.P., Kleeberger S.R. Antiviral activity of Nrf2 in a murine model of respiratory syncytial virus disease. Am. J. Respir. Crit. Care Med. 2009, 179:138-150.
6. Feldmann H., Klenk H.D. Filoviruses. Medical Microbiology 1996, University of Texas Medical Branch, Galveston. 4th edition. S. Baron (Ed.).
7. Feldmann H., Klenk H.D., Sanchez A. Molecular biology and evolution of filoviruses. Arch. Virol. Suppl. 1993, 7:81-100.
8. Furukawa M., Xiong Y. BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase. Mol. Cell. Biol. 2005, 25:162-171.
9. Geisbert T.W., Hensley L.E., Larsen T., Young H.A., Reed D.S., Geisbert J.B., Scott D.P., Kagan E., Jahrling P.B., Davis K.J. Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. Am. J. Pathol. 2003, 163:2347-2370.
10. González-Gallego J., García-Mediavilla M.V., Sánchez-Campos S. Hepatitis C virus, oxidative stress and steatosis: current status and perspectives. Curr. Mol. Med. 2011, 11:373-390.
11. Hayes J.D., McMahon M. NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer. Trends Biochem. Sci. 2009, 34:176-188.
12. Hoenen T., Groseth A., de Kok-Mercado F., Kuhn J.H., Wahl-Jensen V. Minigenomes, transcription and replication competent virus-like particles and beyond: reverse genetics systems for filoviruses and other negative stranded hemorrhagic fever viruses. Antiviral Res. 2011, 91:195-208.
13. Hosakote Y.M., Jantzi P.D., Esham D.L., Spratt H., Kurosky A., Casola A., Garofalo R.P. Viral-mediated inhibition of antioxidant enzymes contributes to the pathogenesis of severe respiratory syncytial virus bronchiolitis. Am. J. Respir. Crit. Care Med. 2011, 183:1550-1560.
14. Huang Y., Xu L., Sun Y., Nabel G.J. The assembly of Ebola virus nucleocapsid requires virion-associated proteins 35 and 24 and posttranslational modification of nucleoprotein. Mol. Cell 2002, 10:307-316.
15. Itoh K., Wakabayashi N., Katoh Y., Ishii T., Igarashi K., Engel J.D., Yamamoto M. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 1999, 13:76-86.
16. Jaiswal A.K. Nrf2 signaling in coordinated activation of antioxidant gene expression. Free Radic. Biol. Med. 2004, 36:1199-1207.
17. Journo C., Filipe J., About F., Chevalier S.A., Afonso P.V., Brady J.N., Flynn D., Tangy F., Israël A., Vidalain P.O., et al. NRP/OptineurinCooperates with TAX1BP1 to potentiate the activation of NF-kappaB byhuman T-lymphotropic virus type 1 tax protein. PLoS Pathog. 2009, 5:e1000521.
18. Kang M.I., Kobayashi A., Wakabayashi N., Kim S.G., Yamamoto M. Scaffolding of Keap1 to the actin cytoskeleton controls the function of Nrf2 as key regulator of cytoprotective phase 2 genes. Proc. Natl. Acad. Sci. USA 2004, 101:2046-2051.
19. Kobayashi A., Kang M.I., Okawa H., Ohtsuji M., Zenke Y., Chiba T., Igarashi K., Yamamoto M. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol. Cell. Biol. 2004, 24:7130-7139.
20. Kobayashi A., Kang M.I., Watai Y., Tong K.I., Shibata T., Uchida K., Yamamoto M. Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1. Mol. Cell. Biol. 2006, 26:221-229.
21. Lee D.F., Kuo H.P., Liu M., Chou C.K., Xia W., Du Y., Shen J., Chen C.T., Huo L., Hsu M.C., et al. KEAP1 E3 ligase-mediated downregulation of NF-kappaB signaling by targeting IKKbeta. Mol. Cell 2009, 36:131-140.
22. Li X., Zhang D., Hannink M., Beamer L.J. Crystal structure of the Kelch domain of human Keap1. J.Biol. Chem. 2004, 279:54750-54758.
23. Li X., Zhang D., Hannink M., Beamer L.J. Crystallization and initial crystallographic analysis of the Kelch domain from human Keap1. Acta Crystallogr. D Biol. Crystallogr. 2004, 60:2346-2348.
24. Ligon B.L. Outbreak of Marburg hemorrhagic fever in Angola: a review of the history of the disease and its biological aspects. Semin. Pediatr. Infect. Dis. 2005, 16:219-224.
25. Lo S.C., Li X., Henzl M.T., Beamer L.J., Hannink M. Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signaling. EMBO J. 2006, 25:3605-3617.
26. Ma Q. Role of nrf2 in oxidative stress and toxicity. Annu. Rev. Pharmacol. Toxicol. 2013, 53:401-426.
27. Mahanty S., Bray M. Pathogenesis of filoviral haemorrhagic fevers. Lancet Infect. Dis. 2004, 4:487-498.
28. Mateo M., Reid S.P., Leung L.W., Basler C.F., Volchkov V.E. Ebolavirus VP24 binding to karyopherins is required for inhibition of interferon signaling. J.Virol. 2010, 84:1169-1175.
29. Mateo M., Carbonnelle C., Martinez M.J., Reynard O., Page A., Volchkova V.A., Volchkov V.E. Knockdown of Ebola virus VP24 impairs viralnucleocapsid assembly and prevents virus replication. J.Infect. Dis. 2011, 204(Suppl 3):S892-S896.
30. Mateo M., Carbonnelle C., Reynard O., Kolesnikova L., Nemirov K., Page A., Volchkova V.A., Volchkov V.E. VP24 is a molecular determinant of Ebola virus virulence in guinea pigs. J.Infect. Dis. 2011, 204(Suppl 3):S1011-S1020.
31. Mehedi M., Groseth A., Feldmann H., Ebihara H. Clinical aspects of Marburg hemorrhagic fever. Future Virol. 2011, 6:1091-1106.
32. Mohamadzadeh M. Potential factors induced by filoviruses that lead to immune supression. Curr. Mol. Med. 2009, 9:174-185.
33. Motohashi H., Katsuoka F., Engel J.D., Yamamoto M. Small Maf proteins serve as transcriptional cofactors for keratinocyte differentiation in the Keap1-Nrf2 regulatory pathway. Proc. Natl. Acad. Sci. USA 2004, 101:6379-6384.
34. Ogura T., Tong K.I., Mio K., Maruyama Y., Kurokawa H., Sato C., Yamamoto M. Keap1 is a forked-stem dimer structure with two large spheres enclosing the intervening, double glycine repeat, and C-terminal domains. Proc. Natl. Acad. Sci. USA 2010, 107:2842-2847.
35. Padmanabhan B., Tong K.I., Kobayashi A., Yamamoto M., Yokoyama S. Structural insights into the similar modes of Nrf2 transcription factor recognition by the cytoplasmic repressor Keap1. J.Synchrotron Radiat. 2008, 15:273-276.
36. Pichlmair A., Kandasamy K., Alvisi G., Mulhern O., Sacco R., Habjan M., Binder M., Stefanovic A., Eberle C.A., Goncalves A., et al. Viral immune modulators perturb the human molecular network by common and unique strategies. Nature 2012, 487:486-490.
37. Reid S.P., Leung L.W., Hartman A.L., Martinez O., Shaw M.L., Carbonnelle C., Volchkov V.E., Nichol S.T., Basler C.F. Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation. J.Virol. 2006, 80:5156-5167.
38. Reid S.P., Valmas C., Martinez O., Sanchez F.M., Basler C.F. Ebola virus VP24 proteins inhibit the interaction of NPI-1 subfamily karyopherin alpha proteins with activated STAT1. J.Virol. 2007, 81:13469-13477.
39. Rubins K.H., Hensley L.E., Wahl-Jensen V., Daddario DiCaprio K.M., Young H.A., Reed D.S., Jahrling P.B., Brown P.O., Relman D.A., Geisbert T.W. The temporal program of peripheral blood gene expression in the response of nonhuman primates to Ebola hemorrhagic fever. Genome Biol. 2007, 8:R174.
40. Rushworth S.A., MacEwan D.J., O'Connell M.A. Lipopolysaccharide-induced expression of NAD(P)H:quinone oxidoreductase 1 and heme oxygenase-1 protects against excessive inflammatory responses in human monocytes. J.Immunol. 2008, 181:6730-6737.
41. Sanchez A., Lukwiya M., Bausch D., Mahanty S., Sanchez A.J., Wagoner K.D., Rollin P.E. Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels. J.Virol. 2004, 78:10370-10377.
42. Schaedler S., Krause J., Himmelsbach K., Carvajal-Yepes M., Lieder F., Klingel K., Nassal M., Weiss T.S., Werner S., Hildt E. Hepatitis B virus induces expression of antioxidant response element-regulated genes by activation of Nrf2. J.Biol. Chem. 2010, 285:41074-41086.
43. Schwarz K.B. Oxidative stress during viral infection: a review. Free Radic. Biol. Med. 1996, 21:641-649.
44. Thimmulappa R.K., Lee H., Rangasamy T., Reddy S.P., Yamamoto M., Kensler T.W., Biswal S. Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. J.Clin. Invest. 2006, 116:984-995.
45. Thimmulappa R.K., Fuchs R.J., Malhotra D., Scollick C., Traore K., Bream J.H., Trush M.A., Liby K.T., Sporn M.B., Kensler T.W., et al. Preclinical evaluation of targeting the Nrf2 pathway by triterpenoids (CDDO-Im andCDDO-Me) for protection from LPS-induced inflammatory response and reactive oxygen species in human peripheral blood mononuclear cells and neutrophils. Antioxid. Redox. Signal. 2007, 9:1963-1970.
46. Tong K.I., Katoh Y., Kusunoki H., Itoh K., Tanaka T., Yamamoto M. Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model. Mol. Cell. Biol. 2006, 26:2887-2900.
47. Tong K.I., Padmanabhan B., Kobayashi A., Shang C., Hirotsu Y., Yokoyama S., Yamamoto M. Different electrostatic potentials define ETGE and DLG motifs as hinge and latch in oxidative stress response. Mol. Cell. Biol. 2007, 27:7511-7521.
48. Valmas C., Basler C.F. Marburg virus VP40 antagonizes interferon signaling in a species-specific manner. J.Virol. 2011, 85:4309-4317.
49. Valmas C., Grosch M.N., Schümann M., Olejnik J., Martinez O., Best S.M., Krähling V., Basler C.F., Mühlberger E. Marburg virus evades interferon responses by a mechanism distinct from ebola virus. PLoS Pathog. 2010, 6:e1000721.
50. Volchkov V.E., Volchkova V.A., Ströher U., Becker S., Dolnik O., Cieplik M., Garten W., Klenk H.D., Feldmann H. Proteolytic processing of Marburg virus glycoprotein. Virology 2000, 268:1-6.
51. Warfield K.L., Bradfute S.B., Wells J., Lofts L., Cooper M.T., Alves D.A., Reed D.K., VanTongeren S.A., Mech C.A., Bavari S. Development and characterization of a mouse model for Marburg hemorrhagic fever. J.Virol. 2009, 83:6404-6415.
52. Will C., Mühlberger E., Linder D., Slenczka W., Klenk H.D., Feldmann H. Marburg virus gene 4 encodes the virion membrane protein, a type I transmembrane glycoprotein. J.Virol. 1993, 67:1203-1210.
53. Zhang H.S., Li H.Y., Zhou Y., Wu M.R., Zhou H.S. Nrf2 is involved in inhibiting Tat-induced HIV-1 long terminal repeat transactivation. Free Radic. Biol. Med. 2009, 47:261-268.